News About: Pharm. Industry
Systematic management for health foods eyed
The Korea Food and Drug Administration (KFDA) says it is contemplating a series of new measures designed to ameliorate health foods-regulations, including:
- The mandatory description scope on the adverse reactions...
More pharmaceutical firms promoting M&A
Pharmaceutical business sources say that the merger and acquisition (M&A) boom is fast spreading among domestic large pharmaceutical firms, including multinationals, in the wake of the inception of the previous IMF re...
Increasing number of foreign firms to establish their production bases in Southeast Asia
Pharmaceutical industry sources says that the domestic deindustralization of drug production and unemployment issues will be inevitably on the rise, due to the recent trend that increasing number of foreign invested p...
Domestic major pharmaceutical firms favors strategic partnership with promising venture
The Korea Drug Research Association (KDRA) says that its15-day survey conducted on last month disclosed that 97 percent of its 28 members polled said they would agree with the necessity of outsourcing for their R&D ne...
Pharmaceutical firms fared well in 2001
The combined turnover of the 30 major pharmaceutical firms in 2001 marked the average growth rate of 15.4 percent from 2000, according to a survey of 2001 performance records of domestic pharmaceutical firms conducted...
Searle Korea plant in Hoengsung to close from July 1.
It is reported that the Hoengsung plant of G. D. Searle Korea would be closed down from July 1 this year.
An insider of Pharmacia said "The plant shut-down was under consideration from last year because two plants...
Drink vitamin C market contested by 20 domestic pharmaceutical firms
Business sources say that stimulated by the biggest sales of Vita 500 marketed by Kwangdong Pharm last year, the domestic drink vitamin C market has emerged as an arena of cur-throat competition among 20 domestic drug...
Turnover of domestic pharmaceutical firms up 8% in first quarter
The combined turnover of the 22 major domestic pharmaceutical firms (except for Korea Green Cross, Chong Kun Dang Corp., and Chong Kun Dang Bio) in the first quarter of this year marked 629.9 billion won, representing...
Foundation of Korea Bio-pharmaceutical Center going unclear.
The KPMA and the Korea Health Industry Promotion Board (hereinafter called Promotion Board) tried to set up "Korea Bio-pharmaceutical Center" in Scotland, the Mecca of Bio-pharmaceutical industry, but faced a lot of c...
Sales promotion for physicians to raise serious problems.
The lavish sales promotional activities toward physicians by pharmaceutical companies raised too serious problems, keeping physician's prescriptions with expensive branded drugs, which in turn deteriorates the NHI fin...
